{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/62d20dbcffef490011c8df4b/62ee238f69245300142b105b?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"2. Metastatic Melanoma","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/62d20dbcffef490011c8df4b/1687409512000-3ccbc326c65042a63b2cbdd84d0ab9ec.jpeg?height=200","description":"<p>In this episode, Josh and Michael discuss the incredible story of the treatment of metastatic melanoma, the immunotherapy revolution, and why this relegated a perfectly decent targeted therapy to second place on the podium. Join us for a titanic battle on a par with Macbeth vs Macduff, Rocky Balboa vs Apollo Creed, or Regina George vs that bus...</p><p><br></p><p>Links to papers discussed (subscription may be required):</p><p>CHECKMATE-067: <a href=\"https://www.nejm.org/doi/full/10.1056/nejmoa1910836\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.nejm.org/doi/full/10.1056/nejmoa1910836</a></p><p>COMBI-D: <a href=\"https://www.nejm.org/doi/full/10.1056/NEJMoa1904059\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.nejm.org/doi/full/10.1056/NEJMoa1904059</a></p><p><br></p><p>For more episodes, resources and blog posts, visit <strong>inquisitiveonc.com</strong></p><p>Find us on Twitter <strong>@InquisitiveOnc!</strong></p><p>If you want us to look at a specific trial or subject, email us at<strong> inquisitiveonc@gmail.com</strong></p><p><br></p><p>Cover art courtesy of Taryn Silver</p><p>Music courtesy of AlexiAction: https://pixabay.com/users/alexiaction-26977400/</p><p><br></p><p><strong>Disclaimer:</strong> This podcast is for educational purposes only. If you are unwell, seek medical advice.</p>","author_name":"Michael Fernando and Josh Hurwitz"}